InvestorsHub Logo
Followers 466
Posts 26932
Boards Moderated 2
Alias Born 09/11/2006

Re: None

Monday, 02/11/2008 4:35:12 PM

Monday, February 11, 2008 4:35:12 PM

Post# of 185
Vertex Pharmaceuticals Reviews 2008 Business Priorities and Reports 2007 Financial Results
Monday February 11, 4:00 pm ET
-- Focused on first-to-market opportunity with HCV protease inhibitor telaprevir --
-- Additional drug candidates directed at HCV, cystic fibrosis and immune-mediated diseases--

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX - News) today reviewed its 2008 business priorities and reported consolidated financial results for the year ended December 31, 2007.

http://biz.yahoo.com/bw/080211/20080211006421.html?.v=1


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VRTX News